BEGIN:VCALENDAR VERSION:2.0 PRODID:-//International Psoriasis Council - ECPv6.16.2//NONSGML v1.0//EN CALSCALE:GREGORIAN METHOD:PUBLISH X-ORIGINAL-URL:https://psoriasiscouncil.org X-WR-CALDESC:Events for International Psoriasis Council REFRESH-INTERVAL;VALUE=DURATION:PT1H X-Robots-Tag:noindex X-PUBLISHED-TTL:PT1H BEGIN:VTIMEZONE TZID:Europe/Amsterdam BEGIN:DAYLIGHT TZOFFSETFROM:+0100 TZOFFSETTO:+0200 TZNAME:CEST DTSTART:20210328T010000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:+0200 TZOFFSETTO:+0100 TZNAME:CET DTSTART:20211031T010000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:+0100 TZOFFSETTO:+0200 TZNAME:CEST DTSTART:20220327T010000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:+0200 TZOFFSETTO:+0100 TZNAME:CET DTSTART:20221030T010000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:+0100 TZOFFSETTO:+0200 TZNAME:CEST DTSTART:20230326T010000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:+0200 TZOFFSETTO:+0100 TZNAME:CET DTSTART:20231029T010000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:+0100 TZOFFSETTO:+0200 TZNAME:CEST DTSTART:20240331T010000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:+0200 TZOFFSETTO:+0100 TZNAME:CET DTSTART:20241027T010000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:+0100 TZOFFSETTO:+0200 TZNAME:CEST DTSTART:20250330T010000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:+0200 TZOFFSETTO:+0100 TZNAME:CET DTSTART:20251026T010000 END:STANDARD END:VTIMEZONE BEGIN:VTIMEZONE TZID:Europe/Paris BEGIN:DAYLIGHT TZOFFSETFROM:+0100 TZOFFSETTO:+0200 TZNAME:CEST DTSTART:20210328T010000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:+0200 TZOFFSETTO:+0100 TZNAME:CET DTSTART:20211031T010000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:+0100 TZOFFSETTO:+0200 TZNAME:CEST DTSTART:20220327T010000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:+0200 TZOFFSETTO:+0100 TZNAME:CET DTSTART:20221030T010000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:+0100 TZOFFSETTO:+0200 TZNAME:CEST DTSTART:20230326T010000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:+0200 TZOFFSETTO:+0100 TZNAME:CET DTSTART:20231029T010000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:+0100 TZOFFSETTO:+0200 TZNAME:CEST DTSTART:20240331T010000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:+0200 TZOFFSETTO:+0100 TZNAME:CET DTSTART:20241027T010000 END:STANDARD END:VTIMEZONE BEGIN:VTIMEZONE TZID:America/Chicago BEGIN:DAYLIGHT TZOFFSETFROM:-0600 TZOFFSETTO:-0500 TZNAME:CDT DTSTART:20220313T080000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0500 TZOFFSETTO:-0600 TZNAME:CST DTSTART:20221106T070000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:-0600 TZOFFSETTO:-0500 TZNAME:CDT DTSTART:20230312T080000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0500 TZOFFSETTO:-0600 TZNAME:CST DTSTART:20231105T070000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:-0600 TZOFFSETTO:-0500 TZNAME:CDT DTSTART:20240310T080000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0500 TZOFFSETTO:-0600 TZNAME:CST DTSTART:20241103T070000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:-0600 TZOFFSETTO:-0500 TZNAME:CDT DTSTART:20250309T080000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0500 TZOFFSETTO:-0600 TZNAME:CST DTSTART:20251102T070000 END:STANDARD END:VTIMEZONE BEGIN:VTIMEZONE TZID:Asia/Tokyo BEGIN:STANDARD TZOFFSETFROM:+0900 TZOFFSETTO:+0900 TZNAME:JST DTSTART:20220101T000000 END:STANDARD END:VTIMEZONE BEGIN:VTIMEZONE TZID:America/New_York BEGIN:DAYLIGHT TZOFFSETFROM:-0500 TZOFFSETTO:-0400 TZNAME:EDT DTSTART:20220313T070000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0400 TZOFFSETTO:-0500 TZNAME:EST DTSTART:20221106T060000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:-0500 TZOFFSETTO:-0400 TZNAME:EDT DTSTART:20230312T070000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0400 TZOFFSETTO:-0500 TZNAME:EST DTSTART:20231105T060000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:-0500 TZOFFSETTO:-0400 TZNAME:EDT DTSTART:20240310T070000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0400 TZOFFSETTO:-0500 TZNAME:EST DTSTART:20241103T060000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:-0500 TZOFFSETTO:-0400 TZNAME:EDT DTSTART:20250309T070000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0400 TZOFFSETTO:-0500 TZNAME:EST DTSTART:20251102T060000 END:STANDARD END:VTIMEZONE BEGIN:VTIMEZONE TZID:Asia/Singapore BEGIN:STANDARD TZOFFSETFROM:+0800 TZOFFSETTO:+0800 TZNAME:+08 DTSTART:20220101T000000 END:STANDARD END:VTIMEZONE BEGIN:VTIMEZONE TZID:Atlantic/Faroe BEGIN:DAYLIGHT TZOFFSETFROM:+0000 TZOFFSETTO:+0100 TZNAME:WEST DTSTART:20220327T010000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:+0100 TZOFFSETTO:+0000 TZNAME:WET DTSTART:20221030T010000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:+0000 TZOFFSETTO:+0100 TZNAME:WEST DTSTART:20230326T010000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:+0100 TZOFFSETTO:+0000 TZNAME:WET DTSTART:20231029T010000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:+0000 TZOFFSETTO:+0100 TZNAME:WEST DTSTART:20240331T010000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:+0100 TZOFFSETTO:+0000 TZNAME:WET DTSTART:20241027T010000 END:STANDARD END:VTIMEZONE BEGIN:VTIMEZONE TZID:America/Los_Angeles BEGIN:DAYLIGHT TZOFFSETFROM:-0800 TZOFFSETTO:-0700 TZNAME:PDT DTSTART:20220313T100000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0700 TZOFFSETTO:-0800 TZNAME:PST DTSTART:20221106T090000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:-0800 TZOFFSETTO:-0700 TZNAME:PDT DTSTART:20230312T100000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0700 TZOFFSETTO:-0800 TZNAME:PST DTSTART:20231105T090000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:-0800 TZOFFSETTO:-0700 TZNAME:PDT DTSTART:20240310T100000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0700 TZOFFSETTO:-0800 TZNAME:PST DTSTART:20241103T090000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:-0800 TZOFFSETTO:-0700 TZNAME:PDT DTSTART:20250309T100000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0700 TZOFFSETTO:-0800 TZNAME:PST DTSTART:20251102T090000 END:STANDARD END:VTIMEZONE BEGIN:VTIMEZONE TZID:Europe/Rome BEGIN:DAYLIGHT TZOFFSETFROM:+0100 TZOFFSETTO:+0200 TZNAME:CEST DTSTART:20220327T010000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:+0200 TZOFFSETTO:+0100 TZNAME:CET DTSTART:20221030T010000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:+0100 TZOFFSETTO:+0200 TZNAME:CEST DTSTART:20230326T010000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:+0200 TZOFFSETTO:+0100 TZNAME:CET DTSTART:20231029T010000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:+0100 TZOFFSETTO:+0200 TZNAME:CEST DTSTART:20240331T010000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:+0200 TZOFFSETTO:+0100 TZNAME:CET DTSTART:20241027T010000 END:STANDARD END:VTIMEZONE BEGIN:VTIMEZONE TZID:Europe/Madrid BEGIN:DAYLIGHT TZOFFSETFROM:+0100 TZOFFSETTO:+0200 TZNAME:CEST DTSTART:20230326T010000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:+0200 TZOFFSETTO:+0100 TZNAME:CET DTSTART:20231029T010000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:+0100 TZOFFSETTO:+0200 TZNAME:CEST DTSTART:20240331T010000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:+0200 TZOFFSETTO:+0100 TZNAME:CET DTSTART:20241027T010000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:+0100 TZOFFSETTO:+0200 TZNAME:CEST DTSTART:20250330T010000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:+0200 TZOFFSETTO:+0100 TZNAME:CET DTSTART:20251026T010000 END:STANDARD END:VTIMEZONE BEGIN:VTIMEZONE TZID:America/New_York BEGIN:DAYLIGHT TZOFFSETFROM:-0500 TZOFFSETTO:-0400 TZNAME:EDT DTSTART:20230312T070000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0400 TZOFFSETTO:-0500 TZNAME:EST DTSTART:20231105T060000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:-0500 TZOFFSETTO:-0400 TZNAME:EDT DTSTART:20240310T070000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0400 TZOFFSETTO:-0500 TZNAME:EST DTSTART:20241103T060000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:-0500 TZOFFSETTO:-0400 TZNAME:EDT DTSTART:20250309T070000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0400 TZOFFSETTO:-0500 TZNAME:EST DTSTART:20251102T060000 END:STANDARD END:VTIMEZONE BEGIN:VTIMEZONE TZID:Europe/Stockholm BEGIN:DAYLIGHT TZOFFSETFROM:+0100 TZOFFSETTO:+0200 TZNAME:CEST DTSTART:20230326T010000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:+0200 TZOFFSETTO:+0100 TZNAME:CET DTSTART:20231029T010000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:+0100 TZOFFSETTO:+0200 TZNAME:CEST DTSTART:20240331T010000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:+0200 TZOFFSETTO:+0100 TZNAME:CET DTSTART:20241027T010000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:+0100 TZOFFSETTO:+0200 TZNAME:CEST DTSTART:20250330T010000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:+0200 TZOFFSETTO:+0100 TZNAME:CET DTSTART:20251026T010000 END:STANDARD END:VTIMEZONE BEGIN:VTIMEZONE TZID:Europe/Paris BEGIN:DAYLIGHT TZOFFSETFROM:+0100 TZOFFSETTO:+0200 TZNAME:CEST DTSTART:20230326T010000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:+0200 TZOFFSETTO:+0100 TZNAME:CET DTSTART:20231029T010000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:+0100 TZOFFSETTO:+0200 TZNAME:CEST DTSTART:20240331T010000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:+0200 TZOFFSETTO:+0100 TZNAME:CET DTSTART:20241027T010000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:+0100 TZOFFSETTO:+0200 TZNAME:CEST DTSTART:20250330T010000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:+0200 TZOFFSETTO:+0100 TZNAME:CET DTSTART:20251026T010000 END:STANDARD END:VTIMEZONE BEGIN:VTIMEZONE TZID:Europe/London BEGIN:DAYLIGHT TZOFFSETFROM:+0000 TZOFFSETTO:+0100 TZNAME:BST DTSTART:20230326T010000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:+0100 TZOFFSETTO:+0000 TZNAME:GMT DTSTART:20231029T010000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:+0000 TZOFFSETTO:+0100 TZNAME:BST DTSTART:20240331T010000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:+0100 TZOFFSETTO:+0000 TZNAME:GMT DTSTART:20241027T010000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:+0000 TZOFFSETTO:+0100 TZNAME:BST DTSTART:20250330T010000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:+0100 TZOFFSETTO:+0000 TZNAME:GMT DTSTART:20251026T010000 END:STANDARD END:VTIMEZONE BEGIN:VTIMEZONE TZID:Asia/Shanghai BEGIN:STANDARD TZOFFSETFROM:+0800 TZOFFSETTO:+0800 TZNAME:CST DTSTART:20230101T000000 END:STANDARD END:VTIMEZONE BEGIN:VEVENT DTSTART;TZID=Europe/Amsterdam:20220928T130000 DTEND;TZID=Europe/Amsterdam:20220928T160000 DTSTAMP:20260516T235203 CREATED:20220617T134900Z LAST-MODIFIED:20230129T021038Z UID:10000132-1664370000-1664380800@psoriasiscouncil.org SUMMARY:Symposium: Psoriasis: What We Have Learned and Where We Are Going DESCRIPTION:Agenda\nPART ONE: LECTURES \nWelcome and Introduction \nLars Iversen \nPsoriasis in the Last Millennium \nPeter van de Kerkhof \nPsoriasis and Genetics \nJonathan Barker \nPsoriasis and the Immune System \nGeorg Stingl \nCurrent and Novel Treatments \nFilip Rob \nBiomarkers in Psoriasis Treatment – Today and in the Future \nLone Skov \nNon-pharmacological Management Today and in the Future \nAlexander Navarini \nLong-term Remission\, Inflammatory Memory & Disease Modification \nCurdin Conrad \nPanel Discussion \nAll faculty \nBREAK \nPART TWO: POSTER PRESENTATIONS \nBlocking Interleukin-17 in Psoriasis: Real-world Experience from the PsoPlus Cohort \nLisa Schots – Ghent University Hospital\, Ghent\, Belgium \nIL-17A+ Mast Cells in Resolved Psoriasis \nTheresa Benezeder – Medical University of Graz\, Graz\, Austria \nGenomic and Epigenomic Rofiling of “Invisible Scar” in Psoriatic Resolved Skin \nAmeneh Ghaffarinia – Skin Research Group\, Szeged\, Hungary \nPathogenic Relationship between Psoriasis and Obesity: An Ex Vivo Study \nGiulia Briatico – University of Campania\, Napoli\, Campania\, Italy \nUsing Single-Cell Transcriptomics to Characterise Early Mechanisms of Disease Remission in Psoriasis \nLuc Francis – St. John’s Institute of Dermatology\, London\, England\, United Kingdom \nCytokine Imbalance During Targeted Therapies for Psoriasis and Atopic Dermatitis – The Yin Yang of Th17 and Th2 \nFrancesco Messina – University Hospital CHUV\, Lausanne\, Switzerland \nDefining Paradoxical Psoriasis and Deep Tissue Immune Cell Profiling \nDavid Croitoru – University of Toronto\, Toronto\, Ontario\, Canada \nADJOURN \n  \nProgram Chair\n \n Bio\n \n  \nProgram Faculty\n \n Bio\n \n Bio\n \n Bio\n \n Bio\n \n Bio\n \n Bio\n \n Bio\n \nYou must be registered for ESDR to attend the IPC symposium. URL:https://psoriasiscouncil.org/event/esdr_2022/ LOCATION:Effectenbeurszaal – Room 1\, Ground Floor\, Netherlands CATEGORIES:Past Events - 2022 ATTACH;FMTTYPE=image/png:https://psoriasiscouncil.org/wp-content/uploads/2022/06/ESDR-event.avif END:VEVENT BEGIN:VEVENT DTSTART;TZID=Europe/Paris:20221003T163000 DTEND;TZID=Europe/Paris:20221003T170000 DTSTAMP:20260516T235203 CREATED:20220920T164124Z LAST-MODIFIED:20230518T174225Z UID:10000155-1664814600-1664816400@psoriasiscouncil.org SUMMARY:Webinar: Monkeypox and Psoriasis Patients – What a Dermatologist Needs to Know DESCRIPTION:Agenda\nWelcome and Introduction \nJoel Gelfand \nClinical and Epidemiological Findings from Monkeypox Outbreak in Spain \nAlba Català \nTalking to Your High-risk Patients about Monkeypox \nErica Dommasch \nDiscussion \nLluís Puig\, All \nProgram Chairs\n \n Bio\n \n Bio\n \nProgram Faculty\n \n Bio\n \n Bio URL:https://psoriasiscouncil.org/event/webinar-monkeypox/ CATEGORIES:Past Events - 2022 ATTACH;FMTTYPE=image/png:https://psoriasiscouncil.org/wp-content/uploads/2022/08/14.avif END:VEVENT BEGIN:VEVENT DTSTART;TZID=Europe/Paris:20230119T153000 DTEND;TZID=Europe/Paris:20230119T163000 DTSTAMP:20260516T235203 CREATED:20221116T014532Z LAST-MODIFIED:20230220T200514Z UID:10000157-1674142200-1674145800@psoriasiscouncil.org SUMMARY:Global Webinar 1: Current Knowledge and Future Directions: Psoriasis and Heart Disease DESCRIPTION:Agenda\nWelcome and Introduction \nAndy Blauvelt \nPathophysiologic Links Between Psoriasis and Heart Disease \nMichael Garshick \nExploring Whether Systemic Therapy for Psoriasis Improves Heart Disease in Clinical Trials \nJoel Gelfand \nInvestigating Real-World Databases to Determine Whether Systemic Therapy for Psoriasis Improves Heart Disease \nMona Ståhle \nQ & A and Closing Comments \nAndy Blauvelt \n  \nProgram Chair\n \n Bio\n \nProgram Faculty\n \n Bio\n \n Bio\n \n Bio URL:https://psoriasiscouncil.org/event/gw1-psoriasis-heart-disease/ CATEGORIES:Past Events - 2023 ATTACH;FMTTYPE=image/png:https://psoriasiscouncil.org/wp-content/uploads/2022/08/14.avif END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Chicago:20230316T140000 DTEND;TZID=America/Chicago:20230316T170000 DTSTAMP:20260516T235203 CREATED:20230214T200125Z LAST-MODIFIED:20230425T184240Z UID:10000151-1678975200-1678986000@psoriasiscouncil.org SUMMARY:Symposium: Psoriasis: Using the Right Treatment in the Right Patient at the Right Time DESCRIPTION:Agenda\nPART ONE: LECTURES \nWelcome and Introduction\nPeter van de Kerkhof \nPrecision Medicine\, Including Early Active Intervention \nChristopher Griffiths \nCutting Edge Topical Medications\nLinda Stein Gold \nCutting Edge Systemic Treatments: Oral and Biologic\nAlexander Egeberg \nConsidering Comorbidities in Treatment Planning \nAndrew Blauvelt \nPanel Discussion \nLinda Stein Gold\, facilitator \nBREAK \nPART TWO: CHALLENGING CASES \nChallenging Case 1: A Patient with GPP\nJaquelini Barboza da Silva \nChallenging Case 2: A Patient with Multiple Comorbidities\nÁlvaro González-Cantero \nChallenging Case 3: A Patient with Active Cancer\nMatt Vesely \nQ & A – Speaker Panel\nPeter van de Kerkhof\, facilitator \nCLOSING COMMENTS AND ADJOURN\nPeter van de Kerkhof \n  \nProgram Chairs\n \n Bio\n \n Bio\n \nProgram Faculty\n \n Bio\n \n Bio\n \n Bio\n \nCase Presenters\n \n Bio\n \n Bio\n \n Bio\n \n\nThis symposium is supported in part by \nLead Sponsors \n              \n Supporting Sponsor\n \n  \nThe content of this session and opinions expressed by presenters are those of the respective presenting society or presenters and do not represent an endorsement by\, nor imply that the session content has been evaluated or approved by the American Academy of Dermatology or corporate sponsors. URL:https://psoriasiscouncil.org/event/symposium-aad2023/ LOCATION:New Orleans Ernest N. Morial Convention Center | Room 275/276/277\, Floor 2 CATEGORIES:Past Events - 2023 ATTACH;FMTTYPE=image/png:https://psoriasiscouncil.org/wp-content/uploads/2022/06/AAD-Event.avif END:VEVENT BEGIN:VEVENT DTSTART;TZID=Europe/Paris:20230418T153000 DTEND;TZID=Europe/Paris:20230418T163000 DTSTAMP:20260516T235203 CREATED:20230221T015321Z LAST-MODIFIED:20230502T183440Z UID:10000160-1681831800-1681835400@psoriasiscouncil.org SUMMARY:Global Webinar 2: Psoriasis in Patients with Cancer or Chronic Infections DESCRIPTION:Agenda\nWelcome and Introduction\nLluís Puig\, MD\, PhD\, Spain \nPsoriasis and Cancer: Epidemiologic Association\nLone Skov\, MD\, PhD\, Denmark \nPsoriasis Treatment and Cancer: New Perspectives\nPaolo Gisondi\, MD\, Italy \nPsoriasis Treatment and Chronic Infections\nRicardo Romiti\, MD\, PhD\, Brazil \nQ & A and Closing Comments \nLluís Puig\, MD\, PhD\, Spain \n  \nProgram Chair\n \n Bio\n \nProgram Faculty\n \n Bio\n \n Bio\n \n Bio URL:https://psoriasiscouncil.org/event/psoriasis-in-patients-cancer-chronic-infections/ CATEGORIES:Past Events - 2023 ATTACH;FMTTYPE=image/png:https://psoriasiscouncil.org/wp-content/uploads/2022/08/14.avif END:VEVENT BEGIN:VEVENT DTSTART;TZID=Asia/Tokyo:20230510T113000 DTEND;TZID=Asia/Tokyo:20230510T150000 DTSTAMP:20260516T235203 CREATED:20220827T191253Z LAST-MODIFIED:20230911T191004Z UID:10000152-1683718200-1683730800@psoriasiscouncil.org SUMMARY:Symposium: Disease Memory and Disease Modification in Psoriasis DESCRIPTION:Agenda\nPART ONE: LECTURES \nWelcome and Introduction\nJohann Gudjonsson\, MD\, PhD\, United States \nTissue Resident Memory Cells\nRachael Clark\, MD\, PhD\, United States \nEpigenetic Inflammatory Memory\nLiv Eidsmo\, MD\, PhD\, Denmark \nDisease Modification\nCurdin Conrad\, MD\, Switzerland \nFuture Directions in Psoriasis Research\nNicole Ward\, PhD\, United States \nPanel Discussion\nJohann Gudjonsson\, MD\, PhD\, United States – facilitator \nBREAK \nPART TWO: POSTER PRESENTATIONS \nIntroduction to Poster Presentations\nCurdin Conrad\, MD\, Switzerland \nUncovering Antigen Triggers in Genetically Predisposed Psoriasis Patients\nAsolina Braun\, PhD – Monash University\, Melbourne\, Australia \nThe Clinical and Immunological Features of Immune Checkpoint Inhibitors-Related Psoriasis\nLai-Ying Lu\, MD – Department of Dermatology and Aesthetic Medicine Center\, Jen-Ai Hospital\, Taichung\, Taiwan & Chang Gung Memorial Hospital\, Linkou\, Taoyuan\, Taiwan \nDNA Methyltransferase DNMT1 Deficiency in Keratinocyte Ameliorates IMQ-Induced Psoriasis-Like Dermatitis\nChunyuan Guo – Shanghai Skin Disease Hospital\, Tongji University School of Medicine\, Shanghai\, China \nIxekizumab Reduces Key IL-17 And IL-23 Pathway Genes More Rapidly Than Guselkumab\nLam Tsoi\, PhD – University of Michigan\, Ann Arbor\, Michigan\, United States \nComparative Efficacy of Biologic and Oral Agents in Palmoplantar Psoriasis and Palmoplantar Pustulosis: A Systematic Review and Network Meta-Analysis\nWilson Liao\, MD – University of California San Francisco\, San Francisco\, California\, United States \nEpidermal Keratinocytes from Psoriatic Resolved Skin Keep Disease Residual Transcriptomic and Epigenomic Profiles\nAmeneh Ghaffarinia\, MD – University of Szeged\, Szeged\, Hungary \nEarly Intervention with Secukinumab May Affect the Establishment of Tissue Memory in Psoriasis\nJohann Gudjonsson\, MD\, PhD – University of Michigan\, Ann Arbor\, Michigan\, United States \nRNA-Seq Helps Elucidate the Mechanism Of NB-UVB Through Comparison of The Treated Edges and Centers of Psoriatic Plaques\nSuphagan Boonpethkaew\, MD – Thammasat University\, Bangkok\, Thailand \nClosing Comments and Adjourn\nCurdin Conrad\, MD\, Switzerland \n\nAttendees must be registered for the ISID meeting to attend. Register now!\n  \nProgram Chairs\n \n Bio\n \n Bio\n \nProgram Faculty\n \n Bio\n \n Bio\n \n Bio URL:https://psoriasiscouncil.org/event/symposium-isid2023/ LOCATION:Keio Plaza Hotel Tokyo\, Room C (Nishiki) – 4F (south tower) CATEGORIES:Past Events - 2023 ATTACH;FMTTYPE=image/png:https://psoriasiscouncil.org/wp-content/uploads/2022/08/ISID-Event-Logo.avif END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20230526T130000 DTEND;TZID=America/New_York:20230526T160000 DTSTAMP:20260516T235203 CREATED:20221114T012258Z LAST-MODIFIED:20230911T190932Z UID:10000156-1685106000-1685116800@psoriasiscouncil.org SUMMARY:IPC & SOLAPSO Symposium: Advances in the Management of Psoriasis DESCRIPTION:Agenda\nPART ONE: MANAGEMENT OF HARD TO TREAT AREAS\nWelcome and Introduction to the IPC and SOLAPSO\nRicardo Romiti\, MD\, PhD\, Brazil & Fernando Valenzuela\, MD\, Chile \nAdvances in the Management of Scalp Psoriasis\nClaudia de la Cruz\, MD\, Chile \nHow I Treat the Scalp\nCésar Gonzalez\, MD\, Colombia \nAdvances in the Management of Nail Psoriasis\nEnrique Rivas\, MD\, Guatemala \nHow I Treat the Nails\nFernando Valenzuela\, MD\, Chile \nAdvances in the Management of Palmoplantar Psoriasis\nAnber Tanaka\, MD\, Brazil \nHow I Treat the Palms and Soles\nMarcelo Arnone\, MD\, Brazil \nPanel Discussion\nRicardo Romiti\, MD\, PhD\, Brazil – facilitator \nBREAK\nPART TWO: KEEP UP TO DATE: PSORIASIS IN 2023\nMethotrexate: What Have We Learned in 75 Years\nAngela Londoño\, MSc\, MD\, Colombia \nCLCI in Patients with Psoriasis\nRicardo Romiti\, MD\, PhD\, Brazil \nGPP: Still a Neglected Disease?\nJuan Raul Castro Ayarza\, MD\, Colombia \nWhat´s the Role of Small Molecules in the Treatment of Psoriasis?\nGabriel Magariños\, MD\, Argentina \nNew Biologics\nAndré Esteves de Carvalho\, MD\, PhD\, Brazil \nPanel Discussion\nEnrique Rivas\, MD\, Guatemala – facilitator \n\nAttendees must be registered for the RADLA meeting to attend. Register now!\nProgram Chairs\n \n Bio\n \n Bio\n \n Bio\n \nProgram Faculty\n \n Bio\n \n Bio\n \n Bio\n \n Bio\n \n Bio\n \n Bio\n \n Bio\n \n Bio\n \n  \nSymposium jointly presented with:\n \n  \nThis Symposium is supported in part by Bristol Myers Squibb. URL:https://psoriasiscouncil.org/event/radla-2023-agenda/ LOCATION:Viasoft (UP Expo) – Curitiba\, Room Number 09\, Located at ASA 3 CATEGORIES:Past Events - 2023 ATTACH;FMTTYPE=image/png:https://psoriasiscouncil.org/wp-content/uploads/2022/11/RADLA-2023-Event-Logo.avif END:VEVENT BEGIN:VEVENT DTSTART;TZID=Asia/Singapore:20230703T143000 DTEND;TZID=Asia/Singapore:20230703T173000 DTSTAMP:20260516T235203 CREATED:20220828T010430Z LAST-MODIFIED:20230911T191129Z UID:10000153-1688394600-1688405400@psoriasiscouncil.org SUMMARY:Symposium: Psoriasis Management and Treatment – An International Perspective DESCRIPTION:Agenda\nWELCOME AND INTRODUCTION\nSiew Eng Choon\, MBBS\, FRCP\, Malaysia \nA Patient-Inclusive Approach in the Treatment of Psoriasis: A Principal Without Borders\nClaudia de la Cruz\, MD\, Chile \nAn International Perspective on Value-Based Healthcare\nJo Lambert\, MD\, PhD\, Belgium \nGenetic Differences Across the Globe\nJohann Gudjonsson\, MD\, PhD\, United States \nPitfalls in Diagnosis and Phenotypic Differences Related to Skin of Color\nMohammad Huq\, MBBS. DDSc\, MSc-Dermatology\, MPH\, Bangladesh \nBREAK \nTherapeutic Challenges Related to Skin of Color\nMahira El Sayed\, MSc\, MD\, Egypt \nComorbidities of Psoriasis Across the World\nKathleen Gallant\, MPA\, United States \nAvailability of Therapies Across the World: Data from the GPA\nChris Griffiths\, OBE\, MD\, FMedSci\, United Kingdom \nEvery Patient in the World has the Right to Optimal Treatment \nHoseah Waweru\, MD\, Kenya \nCLOSING COMMENTS AND ADJOURN\nClaudia de la Cruz\, MD\, Chile \n  \nProgram Chairs\n \n Bio\n \n Bio\n \nProgram Faculty\n \n Bio\n \n Bio\n \n Bio\n \n Bio\n \n Bio\n \n Bio\n \n Bio\n \n  \nThis Symposium is supported in part by Bristol Myers Squibb and Eli Lilly and Company. URL:https://psoriasiscouncil.org/event/symposium-wcd2023/ LOCATION:Suntec Singapore Convention & Exhibition Centre | Room Nicoll 1\, Level 3 CATEGORIES:Past Events - 2023 ATTACH;FMTTYPE=image/png:https://psoriasiscouncil.org/wp-content/uploads/2022/08/WCD-Event-Logo.avif END:VEVENT BEGIN:VEVENT DTSTART;TZID=Atlantic/Faroe:20230908T090000 DTEND;TZID=Atlantic/Faroe:20230908T170000 DTSTAMP:20260516T235203 CREATED:20230831T174423Z LAST-MODIFIED:20231120T191223Z UID:10000164-1694163600-1694192400@psoriasiscouncil.org SUMMARY:Virtual Gunnar Lomholt Symposium DESCRIPTION:Agenda\nWelcome and Program Overview\nLone Skov\, MD\, PhD\, Denmark \nGunnar Lomholt’s Story and Thesis \nClaus Zachariae\, MD\, DMSci\, Denmark \nBig Data and Implications to Psoriasis \nTamar Nijsten\, MD\, PhD\, Netherlands \nWhat Genetic Association Tells Us About Phenotype: HLA and Beyond\nMichael Simpson\, MSc\, PhD\, United Kingdom \nBREAK \nComorbidities and Their Causal Relationship\nAlex Tsoi\, MS\, PhD\, United States \nLinking Genetics with Biological Mechanisms\nJohann Gudjonsson\, MD\, PhD\, United States \nKEYNOTE: A Genetic Epidemiologic History of Psoriasis\nJames T. Elder\, MD\, PhD\, United States \nBREAK \nPART TWO \nInflammatory Memory in Psoriasis\nLiv Eidsmo\, MD\, PhD\, Denmark \nImmunogenetic Dissection of Pustular Forms of Psoriasis\nHervé Bachelez\, MD\, PhD\, France \nKEYNOTE: Where is Psoriatic Arthritis Heading?\nOliver Fitzgerald\, MBBCh\, BAO\, MRCPI\, MRCP\, FRCPI\, MD\, Ireland \nThe History of the Faroe Islands\nErland Viberg Joensen\, PhD\, Faroe Islands \nBREAK \nScience and Practice of Therapeutic Drug Monitoring\nCatherine Smith\, MD\, United Kingdom \nTreatment Strategies and Targets for Severe Psoriasis\nUlrich Mrowietz\, MD\, Germany \nThe Need for Real World Evidence\nLone Skov\, MD\, PhD\, Denmark \n60 Years of Psoriasis Therapy: How Things Have Changed\nMatthias Augustin\, MD\, Germany \nClosing Comments and Adjourn\nJonathan Barker\, MD\, FRCP\, United Kingdom \nScientific Committee\n \n Bio\n \n Bio\n \n Bio\n \n Bio\n \nFaculty\n \n Bio\n \n Bio\n \n Bio\n \n Bio\n \n Bio\n \n Bio\n \n Bio\n \n Bio\n \n Bio\n \n Bio\n \n Bio URL:https://psoriasiscouncil.org/event/virtual-gunnar-lomholt-symposium/ CATEGORIES:Past Events - 2023 ATTACH;FMTTYPE=image/png:https://psoriasiscouncil.org/wp-content/uploads/2022/08/14.avif END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20230928T090000 DTEND;TZID=America/New_York:20230928T100000 DTSTAMP:20260516T235203 CREATED:20230516T180852Z LAST-MODIFIED:20231120T191955Z UID:10000162-1695891600-1695895200@psoriasiscouncil.org SUMMARY:Global Webinar 3: Psoriasis and the Joints DESCRIPTION:Agenda\nWelcome and Introduction\nLone Skov\, MD\, PhD\, Denmark \nEarly Signs and Markers of Psoriatic Arthritis and Disease Progression\nBent Deleuran\, MD\, PhD\, Denmark \nWhat’s New in Treatments for Psoriatic Arthritis\nFrank Behrens\, MD\, Germany \nDoes Treatment of Psoriasis Prevent Development of Psoriatic Arthritis?\nAlexis Ogdie\, MD\, MSCE\, United States \nQ & A and Closing Comments \nLone Skov\, MD\, PhD\, Denmark \n  \nProgram Chair\n \n Bio\n \nProgram Faculty\n \n Bio\n \n Bio\n \n Bio\n \n  \nThis symposium is supported in part by Eli Lilly and Company. URL:https://psoriasiscouncil.org/event/global-webinar-3-psoriasis-and-the-joints/ CATEGORIES:Past Events - 2023 ATTACH;FMTTYPE=image/png:https://psoriasiscouncil.org/wp-content/uploads/2022/08/14.avif END:VEVENT BEGIN:VEVENT DTSTART;TZID=Europe/Paris:20231005T120000 DTEND;TZID=Europe/Paris:20231005T141500 DTSTAMP:20260516T235203 CREATED:20230912T190357Z LAST-MODIFIED:20231201T194147Z UID:10000165-1696507200-1696515300@psoriasiscouncil.org SUMMARY:IPC & PDS Virtual Symposium: Conquering the Complexities of Psoriasis in Skin of Color Filipinos DESCRIPTION:Agenda\nWELCOME AND INTRODUCTION\nCynthia Ciriaco-Tan\, MD\, FPDS\, Philippines\nVermen Verallo Rowell\, MD\, Philippines \nSpeaker Introductions\nVermen Verallo Rowell\, MD\, Philippines\nLily Lyralin L. Tumalad\, MD\, FPDS\, Philippines \nPART I: WHAT TO DO WHEN IT BECOMES VERY DIFFICULT \nChallenges in Managing Erythrodermic Psoriasis\nErrol Prens\, MD\, PhD\, Netherlands \nManaging Severe Psoriasis in Patients with Chronic Infection\nTiago Torres\, MD\, PhD\, Portugal \nPsoriasis Management in Patients with Malignancy\nPaolo Gisondi\, MD\, Italy \nQ & A\nPanel \nPART II: REGISTRIES AND RESEARCH FROM THE REGION \nThe Impact of Psoriasis Registries: Regional & Global Perspectives\nHazel Oon\, MD\, MRCP\, Singapore \nNational Psoriasis Registry: Philippines’ Future Direction\nBernadette Arcilla\, MD\, Philippines \nKey Learnings from Studies on Psoriasis in the Philippines\nVermen Verallo Rowell\, MD\, Philippines \nQ & A\nPanel \nCLOSING COMMENTS\nVermen Verallo Rowell\, MD\, Philippines\nLily Lyralin L. Tumalad\, MD\, FPDS\, Philippines \n  \nProgram Chair\n \n Bio\n \n Bio\n \n  \nProgram Faculty\n \n Bio\n \n Bio\n \n Bio\n \n Bio\n \n Bio\n \n  \nSymposium jointly presented with: URL:https://psoriasiscouncil.org/event/conquering-the-complexities-of-psoriasis-in-skin-of-color-filipinos/ ATTACH;FMTTYPE=image/png:https://psoriasiscouncil.org/wp-content/uploads/2023/09/Psoriasis-Philippines-2023-Event-Logo.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=Europe/Paris:20231011T083000 DTEND;TZID=Europe/Paris:20231011T114500 DTSTAMP:20260516T235203 CREATED:20220828T011305Z LAST-MODIFIED:20231120T190851Z UID:10000154-1697013000-1697024700@psoriasiscouncil.org SUMMARY:Symposium: Innovations in the Pathogenesis and Treatment of Psoriasis DESCRIPTION:Agenda\nWELCOME AND INTRODUCTION\nLluís Puig\, MD\, PhD\, Spain \nSESSION ONE: UPDATES ON THE PATHOGENESIS OF PSORIASIS \nNew Insights in the Pathogenesis of Psoriasis\nJohann Gudjonsson\, MD\, PhD\, United States \nUpdates on the Pathogenesis and Treatment of Generalized Pustular Psoriasis\nHervé Bachelez\, MD\, PhD\, France \nPanel Discussion\nLluís Puig\, MD\, PhD\, Spain\, moderator \nSESSION TWO: DISEASE RELAPSE AND PROGRESSION \nNew Understandings of Disease Relapse and Progression\nIrène Gallais Sérézal\, MD\, PhD\, France \nThe Natural History of Psoriasis: Insights into Clinical and Genetic Markers\nAxel Svedbom\, MSc\, PhD\, Sweden \nPanel Discussion\nLluís Puig\, MD\, PhD\, Spain\, moderator \nBREAK \nSESSION THREE: TREATMENT INNOVATIONS \nNew Paradigms in Oral Treatments for Psoriasis\nRichard Warren\, BSc\, MBChB\, MRCP\, PhD\, United Kingdom \nTYK2 Inhibitors for the Treatment of Psoriasis\nRonald Vender\, MD\, FRCPC\, Canada \nPanel Discussion\nLluís Puig\, MD\, PhD\, Spain\, moderator\nRichard Warren\, BSc\, MBChB\, MRCP\, PhD\, United Kingdom\, moderator \nCLOSING COMMENTS AND ADJOURN\nLluís Puig\, MD\, PhD\, Spain \n  \nProgram Chair\n \n Bio\n \n  \nProgram Co-Chairs\n \n Bio\n \n Bio\n \n Bio\n \n  \nProgram Faculty\n \n Bio\n \n Bio\n \n Bio URL:https://psoriasiscouncil.org/event/symposium-eadv2023/ LOCATION:Messe Berlin Congress Center | Room 5\, Level 1 CATEGORIES:Past Events - 2023 ATTACH;FMTTYPE=image/png:https://psoriasiscouncil.org/wp-content/uploads/2022/08/EADV-2023-Event-Logo.avif END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Los_Angeles:20231104T133000 DTEND;TZID=America/Los_Angeles:20231105T120000 DTSTAMP:20260516T235203 CREATED:20230914T174528Z LAST-MODIFIED:20231020T180042Z UID:10000167-1699104600-1699185600@psoriasiscouncil.org SUMMARY:2023 IPC Psoriasis Masterclass – North America DESCRIPTION: URL:https://psoriasiscouncil.org/event/2023-ipc-psoriasis-masterclass-north-america/ LOCATION:Luxor Hotel and Casino ATTACH;FMTTYPE=image/png:https://psoriasiscouncil.org/wp-content/uploads/2022/08/14.avif END:VEVENT BEGIN:VEVENT DTSTART;TZID=Europe/Rome:20231110T091500 DTEND;TZID=Europe/Rome:20231110T120000 DTSTAMP:20260516T235203 CREATED:20230919T191605Z LAST-MODIFIED:20240515T112557Z UID:10000169-1699607700-1699617600@psoriasiscouncil.org SUMMARY:IPC & ARDV Symposium: Psoriasis - A Complex Disease of All Ages DESCRIPTION:Agenda\nPART ONE \nThe Epidemiology of Psoriasis; Insights in Children and Older Adults \nLuigi Naldi\, MD\, Italy \nPsoriasis in Children: Diagnosis. Clinical Presentations\, Comorbidities. Available Treatments \nEmmanuel Mahé\, MD\, PhD\, France \nPatient Registry Data on the Treatment of Psoriasis in Children\nMarieke Seyger\, MD\, PhD\, Netherlands \nTreating Severe Psoriasis in Adult Patients with Severe Psoriasis Less Than 60 Years Old- A Personalized Approach\nMenno de Rie\, MD\, PhD\, Netherlands \nTreating Severe Psoriasis in Patients Over 60 Years Old – The Interplay Between Immunosenescence and Psoriasis\nLluis Puig\, MD\, PhD\, Spain \nDiscussion \nPART TWO \nPsoriasis – Interesting Cases Presented By Residents\n1. Clinical Case 1\n2. Clinical Case 2\n3. Clinical Case 3\n4. Clinical Case 4\n5. Clinical Case 5 \nCLOSING COMMENTS AND ADJOURN \nProgram Chair\n \n Bio\n \n Bio\n \nProgram Faculty\n \n Bio\n \n Bio\n \n Bio\n \n Bio\n \n  \nSymposium jointly presented with: URL:https://psoriasiscouncil.org/event/symposium-ardv2023/ CATEGORIES:Past Events - 2023 ATTACH;FMTTYPE=image/png:https://psoriasiscouncil.org/wp-content/uploads/2023/09/ARDV-2023-Event-Logo.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20231213T063000 DTEND;TZID=America/New_York:20231213T073000 DTSTAMP:20260516T235203 CREATED:20230809T193103Z LAST-MODIFIED:20231227T195717Z UID:10000163-1702449000-1702452600@psoriasiscouncil.org SUMMARY:Global Webinar 4: Psoriasis and the Gut DESCRIPTION:Agenda\nWelcome and Introduction\nAkimichi Morita\, MD\, PhD\, Japan \nGenetic Insights into IBD and Psoriasis: Shared Features and Unique Characteristics\nAlex Tsoi\, MS\, PhD\, United States \nImmunopathogenesis of IBD: Pathways and Therapeutic Challenges\nKiyoshi Takeda\, MD\, PhD\, Japan \nCase Study: The Complex Relationship between IBD and Psoriasis\nFrancis Lai\, MBBS\, FACD\, Australia \nPanel Discussion\nFaculty \nClosing Comments and Adjourn\nAkimichi Morita\, MD\, PhD\, Japan \n  \nProgram Chair\n \n Bio\n \nProgram Faculty\n \n Bio\n \n Bio\n \n Bio URL:https://psoriasiscouncil.org/event/global-webinar-4-psoriasis-and-the-gut/ CATEGORIES:Past Events - 2023 ATTACH;FMTTYPE=image/png:https://psoriasiscouncil.org/wp-content/uploads/2022/08/14.avif END:VEVENT BEGIN:VEVENT DTSTART;TZID=Europe/Madrid:20240118T180000 DTEND;TZID=Europe/Madrid:20240118T203000 DTSTAMP:20260516T235203 CREATED:20230913T195116Z LAST-MODIFIED:20240312T151454Z UID:10000166-1705600800-1705609800@psoriasiscouncil.org SUMMARY:IPC & AEDV Symposium: Tying Up Loose Ends in the Management of Psoriasis DESCRIPTION:Agenda\nWelcome and Introduction \nCardiometabolic Comorbidities in Psoriasis: Bridging the Evidence to Practice Gap\nÁlvaro González-Cantero\, MD\, PhD\, Spain \nGlobal Healthcare Study on Psoriasis: Achievements and Perspectives\nJulia-Tatjana Maul\, MD\, Switzerland \nPsoriasis and Tuberculosis in the Era of New Biologic Therapies\nTiago Torres\, MD\, PhD\, Portugal \nSmall Molecules in Psoriasis: Do Big Things Come in Small Packages? \nLluís Puig\, MD\, PhD\, Spain \nPsoriasis and Sexual Impairment\nAnna López Ferrer\, MD\, PhD\, Spain \nThe Psoriasis – Atopic Dermatitis Spectrum: Overlapping Forms: The Next Frontier\nJosé Manuel Carrascosa\, MD\, PhD\, Spain \nQ & A and Closing Comments \n  \nProgram Chair\n \n Bio\n \nProgram Faculty\n \n Bio\n \n Bio\n \n Bio\n \n Bio\n \n Bio\n \n  \nSymposium jointly presented with: URL:https://psoriasiscouncil.org/event/tying-up-loose-ends-in-the-management-of-psoriasis/ CATEGORIES:Past Events - 2024 ATTACH;FMTTYPE=image/png:https://psoriasiscouncil.org/wp-content/uploads/2023/09/AEDV-2024-Event-Logo.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Los_Angeles:20240307T140000 DTEND;TZID=America/Los_Angeles:20240307T180000 DTSTAMP:20260516T235203 CREATED:20230914T181301Z LAST-MODIFIED:20240509T171958Z UID:10000168-1709820000-1709834400@psoriasiscouncil.org SUMMARY:Symposium: The Comprehensive Care of Psoriasis DESCRIPTION: \nAgenda\nWELCOME AND INTRODUCTION\nJoel Gelfand\, MD\, MSCE\, United States \nImpact of Obesity on Psoriasis\nÁlvaro González-Cantero\, MD\, PhD\, Spain \nChallenging Case: A Patient with Comorbid Solid Organ Malignancy\nMaria-Angeliki Gkini\, MD\, MSc\, PhD\, FRCP\, United Kingdom \nIdentification and Management of Anxiety\, Depression\, and Stigma in Patients with Psoriasis\nEvan Rieder\, MD\, United States \nChallenging Case: A Patient with Infection\nLucas Galimany\, MD\, MSc\, Chile \nEmerging Mechanistic Data Behind Psoriasis and Cardiometabolic Disease\nJohann Gudjonsson\, MD\, PhD\, United States \nHow to Identify Cardiovascular Risk in People with Psoriasis\nJoel Gelfand\, MD\, MSCE\, United States \nInternational Panel: Cardiovascular Disease in the Clinic\nJoel Gelfand\, MD\, MSCE\, United States\nÁlvaro González-Cantero\, MD\, PhD\, Spain\nJohann Gudjonsson\, MD\, PhD\, United States\nAngela Londoño\, MD\, MSc\, Colombia\nYuling Shi\, MD\, PhD\, China \nBREAK \nLatest Advances in Screening\, Diagnosing and Treating Psoriatic Arthritis\nArthur Kavanaugh\, MD\, United States \nChallenging Case: A Pregnant Patient\nSonia Chavez-Alvarez\, MD\, Mexico \nHot Psoriasis Topics\nAndrew Blauvelt\, MD\, MBA\, United States; moderator\nBruce Strober\, MD\, PhD\, United States; moderator \nNETWORKING \nCLOSING COMMENTS AND ADJOURN\nJoel Gelfand\, MD\, MSCE\, United States \n  \nProgram Chair\n \n Bio\n \n  \nProgram Faculty\n \n Bio\n \n Bio\n \n Bio\n \n Bio\n \n Bio\n \n Bio\n \n Bio\n \n Bio\n \n Bio\n \n Bio\n \n Bio\n \n  \n\nThis symposium is supported in part by \nLead Sponsors\n      \nSupporting Sponsors\n           \n  URL:https://psoriasiscouncil.org/event/symposium-aad-2024/ LOCATION:San Diego Convention Center | Room 23ABC\, Upper Level CATEGORIES:Past Events - 2024 ATTACH;FMTTYPE=image/png:https://psoriasiscouncil.org/wp-content/uploads/2022/06/AAD-Event.avif END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20240507T090000 DTEND;TZID=America/New_York:20240507T120000 DTSTAMP:20260516T235203 CREATED:20240319T195342Z LAST-MODIFIED:20240509T171827Z UID:10000174-1715072400-1715083200@psoriasiscouncil.org SUMMARY:IPC & SOLAPSO Symposium: Psoriasis and Infections: A Latin American Prospective DESCRIPTION:Agenda\nWelcome and Introduction to the IPC and SOLAPSO\nAngela Londoño\, MSc\, MD\, Colombia\nFernando Valenzuela\, MD\, Chile \nInfections and Anti TNF\nFernando Valenzuela\, MD\, Chile \nInfections and Anti ILs\nCristina Echeverría\, MD\, Argentina \nTB and Psoriasis Treatments\nRicardo Romitii\, MD\, PhD\, Brazil \nInfections and New Small Molecules\nAngela Londoño\, MSc\, MD\, Colombia \nClinical Cases and LATAM Challenges – Panel Discussion\nGiuliana Castro Vargas\, MD\, Peru\nEnrique Loayza\, MD\, Ecuador \nClosing Remarks\nAngela Londoño\, MSc\, MD\, Colombia\nFernando Valenzuela\, MD\, Chile \n\nAttendees must be registered for the RADLA meeting to attend. Register now!\nProgram Chairs\n \n Bio\n \n Bio\n \nProgram Faculty\n \n Bio\n \n Bio\n \n Bio\n \n Bio\n \n  \nSymposium jointly presented with: URL:https://psoriasiscouncil.org/event/symposium-radla2024/ LOCATION:Swissôtel\, Great Hall 1 CATEGORIES:Past Events - 2024 ATTACH;FMTTYPE=image/png:https://psoriasiscouncil.org/wp-content/uploads/2024/03/RADLA-2024-Event-Logo.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Chicago:20240515T090000 DTEND;TZID=America/Chicago:20240515T120000 DTSTAMP:20260516T235203 CREATED:20240424T013043Z LAST-MODIFIED:20240630T180452Z UID:10000177-1715763600-1715774400@psoriasiscouncil.org SUMMARY:Symposium: Advances in Technologies and Analytics in Understanding Psoriasis Pathophysiology DESCRIPTION:Agenda\nPART I: CURRENT INSIGHTS AND FUTURE DIRECTIONS\nWelcome and Introduction\nJohann Gudjonsson\, MD\, PhD\, United States \nThe Microbiome and Psoriasis\nWilson Liao\, MD\, United States \nTCR Analysis Using Genomics Data\nEmanual Maverakis\, MD\, United States \nStatistical Genomics and Multi-omic Approaches in Advancing Genetic Research for Psoriasis\nAlex Tsoi\, MS\, PhD\, United States \nTowards Personalized Diagnosis and Therapy\nCurdin Conrad\, MD\, Switzerland \nPanel Discussion\nAll Faculty \nBREAK\nPART II: POSTER PRESENTATIONS\nIntroduction to Poster Presentations\nAlex Tsoi\, MS\, PhD\, United States \nGranzyme K Promotes IL-23 Secretion and Keratinocyte Proliferation in Psoriasis\nKatlyn Richardson – University of British Columbia\, Canada \nPrevalence and Association of Psoriasis in Patients with Seborrheic Dermatitis: A Systematic Review and Meta-Analysis\nChristy Chang – University of Illinois at Chicago\, United States \nComparing Itch in Psoriasis\, Atopic Dermatitis\, and Chronic Idiopathic Urticaria: A Meta-Analysis\nJulia L. Gao\, MD – Beth Israel Deaconess Medical Center\, United States \nPeriodontitis as a Risk Factor for Psoriasis\nRudolf E. Schopf\, MD – Johannes Gutenberg University\, Germany \nHeterogeneity of Psoriatic Skin Lesions Identified by a Novel Transcriptomic Based Psoriasis Cell and Immune Score\nSneha Shrotri – Ampel Biosolutions\, United States \nDual Role of Dermal Adipogenesis in Regulating Neutrophil Activation and Regression\nLing-Juan Zhang\, PhD – Xiamen University\, China \nComparative Whole Metagenome Sequencing Analysis in Psoriasis Capitis Patients and Healthy Individuals\nBritta De Pessemier – Ghent University\, Belgium \nComparative Multiomics Study of Inflammatory Skin Diseases Uncover Novel Disease-Specific Heterogeneity in Skin Resident Myeloid Cells\nMehdi Rashighi\, MD – University of Massachusetts – Chan Medical School\, United States \nClosing and Adjourn\nJohann Gudjonsson\, MD\, PhD\, United States \nProgram Chairs\n \n Bio\n \n Bio\n \nProgram Faculty\n \n Bio\n \n Bio\n \n Bio\n \n  \nThis symposium is supported in part by:\nLead Sponsor\n \nSupporting Sponsor URL:https://psoriasiscouncil.org/event/sid-2024/ LOCATION:Hilton Anatole | Cortez Ballroom A&B\, Lobby Level CATEGORIES:Past Events - 2024 ATTACH;FMTTYPE=image/png:https://psoriasiscouncil.org/wp-content/uploads/2024/05/SID-Event-Logo.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=Europe/Stockholm:20240628T174500 DTEND;TZID=Europe/Stockholm:20240628T184500 DTSTAMP:20260516T235203 CREATED:20240503T192902Z LAST-MODIFIED:20240630T180439Z UID:10000178-1719596700-1719600300@psoriasiscouncil.org SUMMARY:GRAPPA & IPC Symposium: Pso Bold: Tackling Challenging Issues in Psoriasis and Psoriatic Arthritis DESCRIPTION:Agenda\nWelcome and Introductions to GRAPPA & IPC\nApril Armstrong\, MD\, MPH\, United States\nClaudia de la Cruz\, MD\, Chile\nOliver FitzGerald\, MD\, Ireland\nBruce Strober\, MD\, PhD\, United States \nChallenges in Diagnosis & Treatment of Psoriasis in Skin of Color\nMahira Hamdy El Sayed\, MSc\, MD\, Egypt \nDiagnosis and Assessment of Axial Psoriatic Arthritis\nVinod Chandran\, MD\, PhD\, Canada \nTranslational Research Resulting in Targeted Treatments for Psoriasis\nBruce Strober\, MD\, PhD\, United States \nDifficult to Treat Psoriatic Arthritis\nPhilip Mease\, MD\, United States \nPanel Discussion\nJoseph Merola\, MD\, MMSc\, United States \nQ&A and Closing\nBruce Strober\, MD\, PhD\, United States \nProgram Faculty\n \n Bio\n \n Bio\n \n Bio\n \n Bio\n \n Bio\n \n Bio\n \n Bio\n \n Bio\n \n  \nSymposium jointly presented with: URL:https://psoriasiscouncil.org/event/symposium-ifpa2024/ LOCATION:Stockholm Waterfront Congress Centre\, C1/C2\, Level 2 CATEGORIES:Past Events - 2024 ATTACH;FMTTYPE=image/png:https://psoriasiscouncil.org/wp-content/uploads/2022/08/13.avif END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20240819T093000 DTEND;TZID=America/New_York:20240819T103000 DTSTAMP:20260516T235203 CREATED:20240614T171438Z LAST-MODIFIED:20240802T021112Z UID:10000180-1724059800-1724063400@psoriasiscouncil.org SUMMARY:Global Webinar 1: The Full Cycle of Psoriasis Care in 2024: Value or Volume? DESCRIPTION:Agenda\nWelcome and Introduction\nDeepak Balak\, MD\, PhD\, MSc\, Netherlands\nRicardo Romiti\, MD\, PhD\, Brazil \nValue-Based Healthcare – A Primer\nWillem Jan Bos\, MD\, PhD\, Netherlands \nSuccesses of Value-Based Healthcare – An Example from The Netherlands\nPaul van der Nat\, MD\, PhD\, Netherlands \nWhat Exists in Dermatology and Psoriasis?\nDeepak Balak\, MD\, PhD\, MSc\, Netherlands \nQ & A and Closing Comments\nDeepak Balak\, MD\, PhD\, MSc\, Netherlands\nRicardo Romiti\, MD\, PhD\, Brazil \n  \nProgram Chair\n \n Bio\n \n Bio\n \nProgram Faculty\n \n Bio\n \n Bio URL:https://psoriasiscouncil.org/event/2024-gw1/ ATTACH;FMTTYPE=image/png:https://psoriasiscouncil.org/wp-content/uploads/2024/07/GW1.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=Europe/Paris:20240904T130000 DTEND;TZID=Europe/Paris:20240904T170000 DTSTAMP:20260516T235203 CREATED:20240314T185322Z LAST-MODIFIED:20240802T021141Z UID:10000173-1725454800-1725469200@psoriasiscouncil.org SUMMARY:IPC & IEC Symposium: From Comparative Pathogenesis to Biomarker-guided Treatments in Psoriasis and Eczema DESCRIPTION:Agenda\nWelcome and Introduction\nJohann Gudjonsson\, MD\, PhD\, United States\nNick Reynolds\, BSc\, MBBS\, MD\, FRCP\, United Kingdom \nThe Comparative Pathogenesis of Psoriasis and Atopic Dermatitis\nJohann Gudjonsson\, MD\, PhD\, United States \nPhenotype Switching\nMichel Gilliet\, MD\, Switzerland \nGenetic and Ethnic Differences in Psoriasis and Atopic Dermatitis\nSara Brown\, MBChB\, MD\, United Kingdom \nPanel Discussion\nFaculty \nBREAK\nAbstract Presentations \nUsing Biomarkers to Inform the Treatment of Atopic Dermatitis\nMarjolein Bruin-Weller\, MD\, PhD\, Netherlands \nUsing Biomarkers to Inform the Treatment of Psoriasis\nSatveer Mahil\, PhD\, MRCP\, United Kingdom \nUsing Biomarkers to Assess the Risk of Comorbidities in Atopic Dermatitis\nChristian Vestergaard\, MD\, PhD\, DMSc\, Denmark \nUsing Biomarkers to Assess the Risk of Comorbidities in Psoriasis\nCatherine Smith\, MD\, United Kingdom \nPanel Discussion\nFaculty \nClosing Comments\nAkimichi Morita\, MD\, PhD\, Nagoya\, Japan\nTiago Torres\, MD\, PhD\, Portugal \nProgram Chairs\n \n Bio\n \n Bio\n \n Bio\n \n Bio\n \n  \nProgram Faculty\n \n Bio\n \n Bio\n \n Bio\n \n Bio\n \n Bio\n \n Bio\n \n  \nSymposium jointly presented with:\n \nThis symposium is supported in part by:\n \nThe sponsorship is provided exclusively to the IPC. URL:https://psoriasiscouncil.org/event/symposium-esdr2024/ LOCATION:Centro de Congressos de Lisboa (CCL)\, Auditorium II\, Level 1 ATTACH;FMTTYPE=image/png:https://psoriasiscouncil.org/wp-content/uploads/2024/07/ESDR.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=Europe/London:20240914T130000 DTEND;TZID=Europe/London:20240915T120000 DTSTAMP:20260516T235203 CREATED:20240613T161022Z LAST-MODIFIED:20240729T191909Z UID:10000179-1726318800-1726401600@psoriasiscouncil.org SUMMARY:IPC Psoriasis Masterclass for North America DESCRIPTION:Welcome to the IPC Psoriasis Masterclass for North America\, an exclusive educational opportunity for early-to-mid-career dermatologists and other healthcare professionals actively managing and treating psoriasis. Focusing on fostering a small group environment\, this FREE program offers an intimate and personalized learning experience\, ensuring each participant receives the utmost attention and support. \nOver the past five years\, we have successfully hosted the IPC Psoriasis Masterclass worldwide\, including the Middle East and Africa\, Latin America\, Eastern Europe\, and Asia\, engaging nearly 1\,000 participants from an impressive 62 countries. We are bringing this unique program to North America for the second time. \nThis Masterclass is led by an esteemed faculty of international experts boasting extensive experience in psoriasis care. Our aim is to equip attendees with cutting-edge skills and knowledge to elevate their careers and become leaders in the field of psoriasis. \nIPC will cover the cost of your 1-night stay at the Loews Chicago O’Hare Hotel and will provide a reception on Saturday\, and breakfast on Sunday before the program begins. \nCME Credit\nThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Chicago Pritzker School of Medicine and the International Psoriasis Council. The University of Chicago Pritzker School of Medicine designates this live activity for a maximum of 8 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity URL:https://psoriasiscouncil.org/event/north-america-mc2024/ LOCATION:Loews Chicago O’Hare Hotel ATTACH;FMTTYPE=image/png:https://psoriasiscouncil.org/wp-content/uploads/2024/07/NA-MC.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20240920T093000 DTEND;TZID=America/New_York:20240920T103000 DTSTAMP:20260516T235203 CREATED:20240722T010034Z LAST-MODIFIED:20240802T034557Z UID:10000182-1726824600-1726828200@psoriasiscouncil.org SUMMARY:Global Webinar 2: The Integrated Practice Unit Model DESCRIPTION:WELCOME + INTRODUCTION \nAdvantages of the Integrated Practice Unit\nSpeaker TBD \nIntegrated Practice Units – An Example from Rheumatology\nFiona Koster\, Netherlands \nProposing a Model for Psoriasis\nElfie Deprez\, Belgium \nQ&A + CLOSING COMMENTS URL:https://psoriasiscouncil.org/event/2024-global-webinar-2/ ATTACH;FMTTYPE=image/png:https://psoriasiscouncil.org/wp-content/uploads/2024/07/GW2.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=Europe/Amsterdam:20240925T083000 DTEND;TZID=Europe/Amsterdam:20240925T114500 DTSTAMP:20260516T235203 CREATED:20240131T022941Z LAST-MODIFIED:20240729T191725Z UID:10000172-1727253000-1727264700@psoriasiscouncil.org SUMMARY:Symposium: Data Driven Care in Psoriasis DESCRIPTION:Agenda\nPART I: CURRENT INSIGHTS AND FUTURE DIRECTIONS \nWelcome and Introduction \nLone Skov\, MD\, PhD\, Denmark \nBig Data: Challenges and Opportunities\nTamar Nijsten\, PhD\, Netherlands \nThe Role of AI in Psoriasis Care: A Vision for the Future\nAlexander Navarini\, MD\, PhD\, Switzerland \nPreventing Psoriatic Arthritis\nFrank Behrens\, MD\, Germany \nSustaining Psoriasis Remission\nSatveer Mahil\, PhD\, MRCP\, United Kingdom \nPanel Discussion\nAll Faculty \nBREAK \nPART II: SPOTLIGHT ON PEDIATRIC PSORIASIS \nIntroduction to Part II\nSatveer Mahil\, PhD\, MRCP\, United Kingdom \nRecent Treatment Advances in Pediatric Psoriasis\nAmy Paller\, MS\, MD\, United States \nRecategorization of Disease Severity in Pediatric Psoriasis\nMarieke Seyger\, MD\, PhD\, Netherlands \nPART III: CHALLENGING CLINICAL CASES \nChallenging Case with a Focus on Pediatrics\nMona El-Kalioby\, MBBCh\, MSc\, MD\, Egypt \nChallenging Case with a Focus on Data Driven Care\nRavi Ramessur\, MD\, United Kingdom \nPanel Discussion\nAll Faculty \nClosing and Adjourn\nLone Skov\, MD\, PhD\, Denmark \nProgram Chairs\n \n Bio\n \n Bio\n \nProgram Faculty\n \n Bio\n \n Bio\n \n Bio\n \n Bio\n \n Bio\n \n Bio\n \n Bio\n \n  URL:https://psoriasiscouncil.org/event/symposium-eadv2024/ LOCATION:RAI Amsterdam\, Room 7.3\, Level 0 ATTACH;FMTTYPE=image/png:https://psoriasiscouncil.org/wp-content/uploads/2024/07/EADV.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=Asia/Shanghai:20241002T073000 DTEND;TZID=Asia/Shanghai:20241003T200000 DTSTAMP:20260516T235203 CREATED:20240719T191224Z LAST-MODIFIED:20240729T191841Z UID:10000181-1727854200-1727985600@psoriasiscouncil.org SUMMARY:IPC Psoriasis Masterclass for Asia DESCRIPTION:The IPC Psoriasis Masterclass is designed for early-career dermatologists who are making treatment decisions and managing patients with psoriasis and are interested in specializing in psoriasis. Focusing on fostering a small group environment\, this FREE program offers an intimate and personalized learning experience\, ensuring each participant receives the utmost attention and support. \nThis Masterclass is led by an esteemed faculty of international experts boasting extensive experience in psoriasis care. Our aim is to equip attendees with cutting-edge skills and knowledge to elevate their careers and become leaders in the field of psoriasis. Through lectures\, panels\, case-based discussions\, and question-answer sessions\, attendees will obtain practical and essential information for their clinical practice. \nThe IPC Masterclass is open to dermatologists who meet the following criteria: \n\nA diploma\, 1st part MSc\, or higher degree in dermatology\nPracticing dermatology within a governmental establishment\, i.e.\, university hospitals\, public hospitals\, rural hospitals\, etc.\nAt least three years of dermatology practice\nDermatologists interested in psoriasis and who see at least two cases of psoriasis per week\n\nGenerously sponsored by our corporate partners\, IPC will cover the cost of your 1-night stay at the Traders Hotel\, Kuala Lumpur\, and will provide lunch during the program and an evening reception at its conclusion. URL:https://psoriasiscouncil.org/event/2024-asia-masterclass/ LOCATION:Kuala Lumpur City Centre ATTACH;FMTTYPE=image/png:https://psoriasiscouncil.org/wp-content/uploads/2024/07/Asia-MC.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=Asia/Shanghai:20241003T073000 DTEND;TZID=Asia/Shanghai:20241003T084000 DTSTAMP:20260516T235203 CREATED:20240320T183115Z LAST-MODIFIED:20240730T201942Z UID:10000175-1727940600-1727944800@psoriasiscouncil.org SUMMARY:Symposium: Optimizing the Management of Plaque Psoriasis: Insights from Experts DESCRIPTION:Agenda\nWelcome and Introduction\nSiew Eng Choon\, Malaysia \nCurrent Medical Treatment Modalities for Psoriasis\nJonathan Barker\, United Kingdom \nIntegrating Lifestyle Modifications into Psoriasis Management\nPravit Asawanonda\, Thailand \nPatient Education and Empowerment in Psoriasis Care\nJonathan Barker\, United Kingdom\nPravit Asawanonda\, Thailand \nQ&A and Closing\nSiew Eng Choon\, Malaysia \nProgram Chairs\n \n Bio\n \n Bio\n \nProgram Faculty\n \n Bio\n \n Bio URL:https://psoriasiscouncil.org/event/symposium-rcd2024/ LOCATION:Kuala Lumpur Convention Center (KLCC) | Conference Hall 2\, Ground Level ATTACH;FMTTYPE=image/png:https://psoriasiscouncil.org/wp-content/uploads/2024/07/RCD-Day-1.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=Asia/Shanghai:20241004T083000 DTEND;TZID=Asia/Shanghai:20241004T094000 DTSTAMP:20260516T235203 CREATED:20240320T184749Z LAST-MODIFIED:20240730T175657Z UID:10000176-1728030600-1728034800@psoriasiscouncil.org SUMMARY:Symposium: The Complete Guide to GPP: From Immunology to Treatment Goals DESCRIPTION:Agenda\nWelcome and Introduction\nAkimichi Morita\, Japan \nUnderstanding GPP Immunology and Inflammation\nJonathan Barker\, United Kingdom \nChallenges in Diagnosing and Assessing GPP\nSiew Eng Choon\, Malaysia \nGPP: Evidence to Guide Treatment Goals and Pathway\nTsen-Fang Tsai\, Taiwan \nQ&A and Closing\nAkimichi Morita\, Japan \nProgram Chairs\n \n Bio\n \n Bio\n \nProgram Faculty\n \n Bio\n \n Bio\n \n  \nThis symposium is supported in part by:\n \n  URL:https://psoriasiscouncil.org/event/symposium-rcd2024-day2/ LOCATION:Kuala Lumpur Convention Center (KLCC) | Conference Hall 2\, Ground Level ATTACH;FMTTYPE=image/png:https://psoriasiscouncil.org/wp-content/uploads/2024/07/RCD-Day-2.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20241031T093000 DTEND;TZID=America/New_York:20241031T093000 DTSTAMP:20260516T235203 CREATED:20240722T181008Z LAST-MODIFIED:20241125T201625Z UID:10000183-1730367000-1730367000@psoriasiscouncil.org SUMMARY:Global Webinar 3 : Can We Deliver the Best Value Yet? DESCRIPTION:WELCOME + INTRODUCTION\nCurdin Conrad\, MD\, Switzerland \nTreatment Options for Guttate Psoriasis\nCurdin Conrad\, MD\, Switzerland \nTreatment Options for Palmoplantar and Nail Psoriasis\nTiago Torres\, MD\, PhD\, Portugal \nTreatment Options for Psoriasis in High Impact Areas\nCristina Echeverría\, MD\, Argentina \nQ&A + CLOSING COMMENTS\nCurdin Conrad\, MD\, Switzerland URL:https://psoriasiscouncil.org/event/24-global-webinar-3/ ATTACH;FMTTYPE=image/png:https://psoriasiscouncil.org/wp-content/uploads/2024/07/GW3.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20241101T093000 DTEND;TZID=America/New_York:20241101T093000 DTSTAMP:20260516T235203 CREATED:20240729T190836Z LAST-MODIFIED:20241210T200739Z UID:10000185-1730453400-1730453400@psoriasiscouncil.org SUMMARY:Global Webinar 4: The Role Doctors and Other Healthcare Practitioners Can Play DESCRIPTION:WELCOME + INTRODUCTION\nChris Griffiths \nTask Delegation in The Clinic: Workforce Redesign\nAnn Van Hecke \nThe Team Approach: An Example from Manchester\nChris Griffiths \nThe Team Approach: Can Costs Drive Reorganization?\nJoke Borzée \nQ&A + CLOSING COMMENTS\nElfie Deprez URL:https://psoriasiscouncil.org/event/global-webinar-4/ ATTACH;FMTTYPE=image/png:https://psoriasiscouncil.org/wp-content/uploads/2024/07/GW4.png END:VEVENT END:VCALENDAR